Share Your Research, Maximize Your Social Impacts
Fast Treatment of Methamphetamine Related Anxiety and Depressive Disorders: A Novel Approach
Journal: Journal of Addiction Medicine and Therapeutic Science (Vol.2, No. 1)Publication Date: 2016-12-26
Authors : Jamshid Ahmadi;
Page : 001-003
Keywords : Methamphetamine related disorders; Buprenorphine; Single dose;
Source : Download
Find it from : Google Scholar
Abstract
Background: Methamphetamine abuse and dependence is currently a considerable problem. Objective: To explain the efficacy of buprenorphine in the quick management of methamphetamine related anxiety and depressive disorders and also methamphetamine withdrawal craving. Results: 52 mg of buprenorphine is very valuable in the treatment of severe methamphetamine related anxiety and depression and also methamphetamine craving.
Other Latest Articles
- Tramadol Dependency Treatment: A New Approach
- The Effects of Substance Abuse Following Personal Injury: Five Case Studies from a Medico-Legal Context
- Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers
- Update on Opioid Addiction for Perioperative and Critical Unit Care: Anaesthesiologists Perspective
- The Effects of Beverage Specific Alcohol Sale on Liver Cirrhosis Mortality in Russia
Last modified: 2018-09-06 14:06:20